Keywords
Hanseniasis
Paucibacillary patients
Polychemotherapy
Paucibacillary patients
Polychemotherapy
How to Cite
1.
AVELLEIRA JC, MARQUES AB, VIANA FR, ANDRADE VLG de. Eficácia da MDT no tratamento de pacientes hansenianos paucibacilares - resultados preliminares. Hansen. Int. [Internet]. 1989 Nov. 30 [cited 2024 Nov. 25];14(2):107-11. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/36497
Abstract
The efficaciousness evaluation of the polychemotherapics regimens recommended by WHO to the hansenian paucibacillary patients, is carried out mainly by the suitable follow up of patients after therapeutic discharge. The criterion for inclusion of patients as paucibacillary ones is another point of importance. The authors based on the follow up of 66 patients that completed treatment and in the abscence of relapses until the moment, advise that together with the clinical classification it should be considered factors like: the Mitsuda test, the number of lesions and the bacilloscopy result.
References
1- ANDRADE, V.L.G.; MARQUES, A.B.; CUNHA, L.H.V.; AVELLEIRA, J.C.R. Feasibility of mul t idrug ther apy (MDT) in Hansen' s Disease in a urban population Curupaiti State Hospital, Rio de Janeiro, Brasil. Int. J. Leprosy, 55:435-440, 1987.
2- BRAKEL, W. ; KIST, P. ; NOBLE, S. ; O'TOOLE, L. Relapses after multidrug therapy for leprosy: a preliminary report of 22 cases in west Nepal. Lepr. Rev., 60(1): 45-50, 1989.
3- DEGUERRY, M.; DECLERCQ, E.; MISSON, C.; VELLUT, C.; BERTRAND, F. Registration of the number of macules in paucibacillary leprosy for evaluation of early diagnosis and individual prognoses. Lepr. Rev. , 60(3):206-213, 1989.
4- EKAMBARAM, V. Du r a t i o n o f t r e a tme n t f o r "disease arrest" of non-lepromatous cases and relapses rate in these patients. Lepr. Rev., 50(4): 297-302, 1979.
5- JESUDASAN, K. & CHRISTIAN, M. Ri sk of paudbacillary leprosy. Int. J. Leprosy, 53(1):19-21, 1985.
6- JESUDASAN, K. ; CHRISTIAN, M. ; BRADLEY, D. Relapse rates among non-lepromatous patientes released from control. Int. J. Leprosy, 52(3):304-310, 1984.
7- K A T O C H , K . ; RAMANATHAN, U. NATRAJAN, M. ; BAGGA, A.K. ; BHATIA, A.S. ; SAXENA, R.K. ; RAMU, G. Relapses In PB patients after treatment with three short regimens containing rifampicin. Int. J. Leprosy, 57:458-464, 1989.
8- ROSE, P. Short-course multi-drug therapy for paucibacillary patients in Guyana: preliminary communicat ion. Lepr. Rev., 55(2):143-147. 1984.
9- TALHARI, S.; CUNHA, M.G.S.; PARREIRA, J.V.; SCHETTINI, A.P.M.; CAVALCANTE, F.H.; TALHARI, A.C. Resultados preliminares com o esquema OMS/81, em pacientes tuberculóides e indeterminados. An. Bras. Dermatol,63(suppl. 1):284-286, 1988.
1 0 - TO UW- L A NG E NDI J K , E .M. J . & NA A F S , B. Relapse in leprosy after release from control. Lepr. Rev., 5012):123-127, 1979.
1 1 - W O R L D H E A L T H O R G A N I Z A T I O N . Chemotherapy of Leprosy for Cont rol Programmes: r epor t of a WHO s tudy g r o u p . G e n e v a , 1 9 8 2 . 3 6 p . (WH O . Technical report series, 675)
12- WORLD HEALTH ORGANIZATION. WHO Exper t Commi t tee o n L e p r o s y : s i x r e p o r t . Ge n e v a , 1 9 8 8 . 5 8 9 . (WHO) . Technical report series, 768).
2- BRAKEL, W. ; KIST, P. ; NOBLE, S. ; O'TOOLE, L. Relapses after multidrug therapy for leprosy: a preliminary report of 22 cases in west Nepal. Lepr. Rev., 60(1): 45-50, 1989.
3- DEGUERRY, M.; DECLERCQ, E.; MISSON, C.; VELLUT, C.; BERTRAND, F. Registration of the number of macules in paucibacillary leprosy for evaluation of early diagnosis and individual prognoses. Lepr. Rev. , 60(3):206-213, 1989.
4- EKAMBARAM, V. Du r a t i o n o f t r e a tme n t f o r "disease arrest" of non-lepromatous cases and relapses rate in these patients. Lepr. Rev., 50(4): 297-302, 1979.
5- JESUDASAN, K. & CHRISTIAN, M. Ri sk of paudbacillary leprosy. Int. J. Leprosy, 53(1):19-21, 1985.
6- JESUDASAN, K. ; CHRISTIAN, M. ; BRADLEY, D. Relapse rates among non-lepromatous patientes released from control. Int. J. Leprosy, 52(3):304-310, 1984.
7- K A T O C H , K . ; RAMANATHAN, U. NATRAJAN, M. ; BAGGA, A.K. ; BHATIA, A.S. ; SAXENA, R.K. ; RAMU, G. Relapses In PB patients after treatment with three short regimens containing rifampicin. Int. J. Leprosy, 57:458-464, 1989.
8- ROSE, P. Short-course multi-drug therapy for paucibacillary patients in Guyana: preliminary communicat ion. Lepr. Rev., 55(2):143-147. 1984.
9- TALHARI, S.; CUNHA, M.G.S.; PARREIRA, J.V.; SCHETTINI, A.P.M.; CAVALCANTE, F.H.; TALHARI, A.C. Resultados preliminares com o esquema OMS/81, em pacientes tuberculóides e indeterminados. An. Bras. Dermatol,63(suppl. 1):284-286, 1988.
1 0 - TO UW- L A NG E NDI J K , E .M. J . & NA A F S , B. Relapse in leprosy after release from control. Lepr. Rev., 5012):123-127, 1979.
1 1 - W O R L D H E A L T H O R G A N I Z A T I O N . Chemotherapy of Leprosy for Cont rol Programmes: r epor t of a WHO s tudy g r o u p . G e n e v a , 1 9 8 2 . 3 6 p . (WH O . Technical report series, 675)
12- WORLD HEALTH ORGANIZATION. WHO Exper t Commi t tee o n L e p r o s y : s i x r e p o r t . Ge n e v a , 1 9 8 8 . 5 8 9 . (WHO) . Technical report series, 768).
This work is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
Download data is not yet available.
